Study to assess merger of Epi-LASIK, wavefront

Duluth, GA-Norwood Abbey Ltd. has launched a 3-month study of postoperative comfort, visual recovery, and wavefront-guided custom ablation with its Centurion SES Epikeratome with EpiEdge for Epi-LASIK for the treatment of myopia.

Marguerite B. McDonald, MD, FACS, will serve as principal investigator and medical monitor; Daniel S. Durrie, MD, and Lee Shahinian, MD, are clinical investigators.

The study will examine how combining Epi-LASIK and wavefront diagnostics would affect visual outcomes. Some 35 patients will be enrolled at each of three U.S. study sites.